Navigation Links
GeneSeek Selects the British Midlands as Base for New UK/European Operations
Date:12/14/2007

US Research and Product Development Company to Establish Presence in

UK/European Market from the Midlands

CHICAGO, Dec. 14 /PRNewswire/ -- Today the British Midlands Development Corporation announced that Nebraska based GeneSeek has chosen the British Midlands as the location for their new European operation.

GeneSeek will be setting up their new base of operations in BioCity Nottingham, the UK's largest bioscience and healthcare innovation center. BioCity provides state-of-the-art laboratories, equipment, and office space for bioscience start-up companies and has the perfect infrastructure for GeneSeek to establish its presence in the European market.

"European expansion is an important component of GeneSeek's growth strategy which also includes new laboratory and offices in India to address the Asian market," said Abe Oommen, President and CEO of GeneSeek, "By selecting BioCity Nottingham as the location for our European operations, we'll be able to leverage the region's skill base, well-established science industry, and access all of our key markets."

"We've worked closely with the investment team at the British Midlands as well as BioCity to make this project happen," said Oommen, "GeneSeek is ready to take on the opportunities in these new markets and launch the next phase of the company's growth."

"GeneSeek and its research and development operations are well suited for the British Midlands," said Vern Sebby, President and CEO of British Midlands Development Corporation, "We have 17-world class universities with UK leading research in genomics and clinical diagnostics, as well as one the strongest science industry clusters in Europe."

"We're thrilled that GeneSeek chose the Midlands," continued Sebby, "We look forward to continuing our support and sharing regional expertise with them as the company's European operations grow."

About GeneSeek

GeneSeek provides comprehensive research and product development solutions for the Life Science, Agribusiness, Pharmaceutical and Biotechnology industries. We provide customers with a full range of solutions, from basic research to high throughput genomic screening for predictive and causative mutations, clinical diagnostics systems and devices, and therapeutic protein production and discovery.

GeneSeek enables development, testing and pilot production under one roof for products ranging from diagnostic SNP panels to biologics for use in agriculture, pharmacogenomics, clinical diagnostics and health care. GeneSeek has developed unique expertise and capabilities that knit together several related fields into one integrated system that incorporates information technology and instrumentation for providing comprehensive high throughput solutions for our clients. For more information, please visit http://www.geneseek.com

About British Midlands Development Corporation

The British Midlands Development Corporation is the North American economic development agency for central England. The Midlands region is located just one hour to the north of London and includes the major commercial centers of Birmingham, Nottingham, Coventry and Northampton.

As an agency funded by the UK Government, The British Midlands Development Corporation provides specialist advice and support to North American companies seeking to establish a presence or expand a current operation in the region. The British Midlands Development Corporation provides access to business networks, details about sources for grants and funding, business support services, and information to help companies identify opportunities to develop and grow.

The British Midlands Development Corporation is based in Chicago with branch offices in Boston, Washington, DC and San Jose.

For more information, please visit our website at http://www.thebritishmidlands.com.

Press Contact

Shirar O'Connor-Mugler

shirar@thepontgroup.com

646 496 7668


'/>"/>
SOURCE British Midlands Development Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
2. Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software
3. E-Rad Solutions Selects Compressus Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market
4. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
5. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
6. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
7. ADM Reorganizes Operations
8. NanoSensors, Inc. Announces Reorganization of Executive Management Team and Redirection of Operations
9. St. Jude Medical to Expand Puerto Rico Operations
10. AviaraDx Announces CAP Accreditation of Its Laboratory Operations
11. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):